ARE YOU A COMMUNITY MEDICAL OR RADIATION ONCOLOGIST?
- Interested In Starting A Radiopharmaceutical Program At Your Center But Seems Complex?
- Interested In Conducting Radiopharmaceutical Clinical Trials But Have No Current Or Limited Clinical Trials Program
- Interested In Helping Fill The Critical Shortage Of Community Cancer Centers Capable Of Conducting Radiopharmaceutical Clinical Trials
XCancer® has the experts and the experience to provide your center with the backbone, tools, strategies, and business models to make you successful at both. XCancer® is a community cancer center with a solo medical oncologist that has developed a leading radiopharmaceutical clinical trials program recognized globally. Using its experience and processes, XCancer® has successfully guided community cancer centers across the United States with developing highly efficient and quality clinical trial programs.
Start your program today:
Physicians
Advanced Knowledge & Opportunites
- Advance your Knowledge of Theranostics, Radiation, & Clinical Trials
- Search a Comprehensive List of Global Oncology-Theranostic clinical trials
- Easy access to Publications & Presentations regarding investigational Theranostic agents
- Opportunities & Access to Strategy Advisors on How to Develop a Theranostic Clinical Trials Program at Your Site
- Access to Clinical Trials Sponsors in search of potential clinical trial sites
- Keep updated of Upcoming Theranostic Conferences
Distinguished Investigator
A Distinguished Investigator of Theranostics is a level of distinction conferred upon an individual physician who has demonstrated a mastery of conducting novel radioligand therapies and molecular imaging clinical trials.
Andrei Iagaru, MD
Dr. Iagaru is a Professor of Radiology - Nuclear Medicine and the Chief of the Division of Nuclear Medicine and Molecular Imaging at Stanford University Medical Center. He completed medical school at Carol Davila University of Medicine, Bucharest, Romania, and an internship at Drexel University College of Medicine, Graduate Hospital, in the Department of Medicine in Philadelphia. He began his residency at the University of Southern California (USC) Keck School of Medicine, Los Angeles, in the Division of Nuclear Medicine. Dr. Iagaru finished his residency and completed a PET/CT fellowship at Stanford University's School of Medicine in the Division of Nuclear Medicine. His research interests include PET/MRI and PET/CT for early cancer detection; clinical translation of novel PET radiopharmaceuticals; peptide-based diagnostic imaging and therapy; targeted radionuclide therapy. Since joining the faculty at Stanford in 2007, Dr. Iagaru has received several awards including the Society of Nuclear Medicine (SNM) 2009 Image of the Year Award; AuntMinnie 2016 Best Radiology Image, American College of Nuclear Medicine (ACNM) Mid-Winter Conference 2010 Best Essay Award; 2009, 2014 and 2015 Western Regional SNM Scientist Award; 2011 SNM Nuclear Oncology Council Young Investigator Award; the 2020 Sanjiv Sam Gambhir Distinguished Scientist Award, Western Regional SNM and the 2022 Sanjiv Sam Gambhir Trailblazer Award, SNMMI. Dr. Iagaru published more than 230 papers in peer-reviewed journals, as well as 9 book chapters and 1 book.
Read MoreRLT Components
RADIOLIGAND THERAPY (RLT) is a highly effective approach to very accurately locating cancer cells and effectively killing those same cells by delivery various radioisotopes to a specific target that is located on a type of cancer. Some of the Radioisotopes are diagnostic for locating cancers & some therapeutic to treat the cancers.
There are several Components to a RLT that are simply demonstrated in the truck diagram including:
- Cancer Targets
- Ligand (demonstrated as the Truck GPS set to find a specific Target)
- Diagnostic Radioisotopes (demonstrated as light bulbs that light the cancer Targets on a PET scan)
- Therapeutic Radioisotopes (demonstrated as bombs that kill cancer cells that express the target with either Alpha or Beta radiation)
- Linker (demonstrated as the hitch keeping the Radioisotope attached to the Ligand)
- Chelator (demonstrated as the Trailers which keeps the Radioisotope on Target).
To learn more about the specific components being studied today on clinical trials around the world check out the RLT COMPONENTSTab.
Education
Stats
Conferences
EANM 2024
EANM is a place to discuss the latest theranostic advances, the most impactful clinical evidence, the most recently developed radiopharmaceuticals, and the most novel imaging and detection technologies. The program focus specifically on facilitating interactions and exchanges across disciplines, competences, and generations.Metals in Medicine
The Metals in Medicine GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field.19th International Conference on Radiopharmaceutical Therapy (ICRT)
The Symposium will bring together Nuclear Medicine leaders, physicians, scientists, healthcare professionals, and others interested in the challenges and advancements related to nuclear medicine and molecular imaging and therapy.21st European Symposium on Radiopharmacy & Radiopharmaceuticals
Hosted by the Institute for Nuclear Sciences Applied to Health (ICNAS), the 21st European Symposium on Radiopharmacy and Radiopharmaceuticals will feature a combination of high-level scientific lectures, back-to-basics educational sessions and fruitful discussions, together with nice social events will make the 21st edition of ESRR successful, continuing its long-standing tradition of excellence.SNMMI Therapeutics Conference Fall 2024
This exciting event will bring together leaders in radiopharmaceutical therapy to explore the latest innovations and advancements in the field. This conference is a must-attend if you want to expand your knowledge and stay up to date on the latest developments in the field. With two-and-a-half days of informative sessions and networking opportunities, you'll have the chance to connect with colleagues, enhance your knowledge, learn from experts, and gain invaluable insights.ESMO Congress 2024
A comprehensive educational and scientific conference that will foster exchange and debate of translational cancer science, showcase first announcements of potentially practice changing data and stimulate multidisciplinary discussions to improve treatment options for our patients.ICPO Virtual Theranostics Summit 2024
World-class scientific program with invited experts from academia and industry in the field of theranostics in precision oncology.6th Annual TRP
Gathering world-class speakers to address the most exciting opportunities and challenges spanning novel targeting mechanisms, alpha vs beta emitters, nuclear medicine clinical expertise, isotope supply, European logistics chains as well as pricing and reimbursement- don’t miss the biggest edition of the 6th Targeted Radiopharmaceuticals Summit to date!ICRIIC '24
The International Conference on Radiology, Imaging and Immunotherapy in Cancer (ICRIIC), hosted by Research Leagues, serves as a premier global platform for sharing the latest advancements and developments in these fields. The goal is to provide a competitive forum for practitioners and researchers from both industry and academia to come together and discuss cutting-edge advances.International Conference on Radiopharmacy and Radiopharmaceuticals (ICRR)
Today more than ever before it is extremely important to stay abreast of the changing landscapes of the Pharmacological and Pharmaceutical Sciences world. The multidisciplinary focus of this event aims to bring together presenters and attendees from different fields with expertise in various areas of Pharmacological and Pharmaceutical Sciences, providing an excellent opportunity to participate in the international exchange of ideas, current strategies, concepts and best practices, collaborations, and cooperation, offering a broader perspective and more enriching experience. The program includes time allocated for networking, peer-to-peer discussions, and exploring the host city.CANM '24
CANM is a key platform offering top-tier educational and networking opportunities for the nuclear medicine and molecular imaging community. The Canadian Association of Nuclear Medicine tirelessly works towards promoting excellence in nuclear medicine practice, fostering professional competence, setting clinical guidelines, and encouraging research. We're committed to ensuring Canadians receive the highest quality nuclear medicine services.Radionuclide Theranostics for the Management of Cancer
The Radionuclide Theranostics for the Management of Cancer GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field.11th Balkan Congress of Nuclear Medicine
The 11th Balkan Congress of Nuclear Medicine is organized by the Macedonian Association of Nuclear Medicine in collaboration with the Balkan Societies of Nuclear Medicine. The event will host nuclear medicine professionals as well as colleagues from other specialties tightly connected to the field of nuclear medicine with it’s diagnostic and therapeutic possibilities. The scientific program will cover the most recent advances and practices in the fields of molecular imaging and therapy with radionuclides.Sponsors
.svg)
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468